Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. AZTA
AZTA logo

AZTA Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Azenta Inc (AZTA) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
26.400
1 Day change
5.43%
52 Week Range
41.730
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Azenta Inc (AZTA) is not a strong buy for a beginner investor with a long-term focus at this moment. The stock's technical indicators are neutral, and there are no strong positive catalysts or proprietary trading signals to support immediate action. Additionally, the financial performance shows limited growth, and analyst ratings have been lowering price targets. It is better to wait for clearer positive signals or improved fundamentals before investing.

Technical Analysis

The MACD is positive but contracting, RSI is neutral at 66.628, and moving averages are converging, indicating no clear trend. The stock is trading near its resistance level (R1: 24.869) with limited upward momentum.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
7
Buy
7

Positive Catalysts

  • No recent news or significant positive catalysts. Analysts note potential long-term benefits from acquisitions, but these are expected to materialize in 2027/28.

Neutral/Negative Catalysts

  • Lowered price targets from multiple analysts, declining gross margins (-8.18% YoY), and a negative net income despite improvement. The stock is also projected to decline in the short term based on candlestick pattern analysis.

Financial Performance

In Q1 2026, revenue increased marginally by 0.82% YoY, net income improved but remains negative (-$15.43M), and EPS improved to -0.34. However, gross margin dropped significantly by 8.18% YoY.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Analysts have lowered price targets recently, with Evercore ISI and Jefferies reducing targets to $35. The stock retains a mix of Buy and Hold ratings, but concerns about gross margins and short-term dilution from acquisitions persist.

Wall Street analysts forecast AZTA stock price to rise
6 Analyst Rating
Wall Street analysts forecast AZTA stock price to rise
4 Buy
2 Hold
0 Sell
Moderate Buy
Current: 25.040
sliders
Low
30
Averages
39.5
High
45
Current: 25.040
sliders
Low
30
Averages
39.5
High
45
Evercore ISI
Outperform
to
Outperform
downgrade
$45 -> $35
AI Analysis
2026-04-06
Reason
Evercore ISI
Price Target
$45 -> $35
AI Analysis
2026-04-06
downgrade
Outperform
to
Outperform
Reason
Evercore ISI lowered the firm's price target on Azenta to $35 from $45 and keeps an Outperform rating on the shares as part of the firm's medical technology and life science tools Q1 preview.
Jefferies
Matthew Stanton
Buy
to
Buy
downgrade
$40 -> $35
2026-04-01
Reason
Jefferies
Matthew Stanton
Price Target
$40 -> $35
2026-04-01
downgrade
Buy
to
Buy
Reason
Jefferies analyst Matthew Stanton lowered the firm's price target on Azenta to $35 from $40 and keeps a Buy rating on the shares. The firm is updating its model for the recent acquisition of UK Biocentre, noting that the deal is expected to be dilutive to adjusted EBITDA pro-forma for fiscal year in 2026 and accretive to 2027/28 organic revenue growth and adjusted EBITDA margin.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for AZTA
Unlock Now

People Also Watch